Business Wire

SULZER

Share
Sulzer: Threefold Increase in Dispensing Rates, and Treatment of Sensitive Materials

Sulzer’s newly developed Blueline cartridge system is designed specifically for the application of highly viscous materials, with a view to enhancing end users’ productivity. Blueline delivers a threefold increase in dispensing rates compared with conventional cartridge systems. It is compatible with commonly used dispensers and will be unveiled at the JEC World 2017 exhibition in Paris.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170314005752/en/

Sulzer Mixpac AG – a subsidiary of Sulzer Ltd., a global leader in the manufacture and supply of liquid application and mixing technology products and services – will showcase its innovative new Blueline cartridge system at JEC World 2017 in Paris.

Dispensing rates up to three times higher

Highly viscous materials push existing cartridge systems to their limits in terms of the achievable dispensing rate. Previously, users would have to make do with small quantities of such materials or switch to considerably more complex mechanical processing of adhesives. Available with 2:1 and 10:1 mixing ratios, the Blueline cartridge system opens up a host of new possibilities.

Applications in aircraft and vehicle construction, general industry and the building sector

Marco Frei, Head Sales Industry EMIRA at Sulzer Mixpac AG, explains: “Blueline extends the range of possible applications for cartridges , allowing end users to boost productivity. Compared with existing systems, it offers considerably higher dispensing rates when applying highly viscous materials. The large cross-sections of the outlets combined with new, optimised mixing geometry increases dispensing rates up to threefold compared with currently available cartridge systems – and all this with the same dispensing force. The interface design features separate outlets from the cartridge to the mixer, removing the risk of unintentional mixing and clogging of the cartridge outlet by material components. This translates into clean and reliable processing of two-component materials.”

Quick, safe and clean processing of sensitive 2-K materials

Honeycomb core and edging filler are applied in two-component (2-K) form in sectors such as aircraft construction. These materials have densities of less than 1g/ml and are formed by adding hollow plastic or glass spheres, which helps to reduce weight. When processing such materials, high pressure and high shear rates cause these spheres to burst, making them unusable. In addition, these materials are also highly viscous, and in some cases there are differences in compressibility between the two components. For these reasons, the options for processing such materials using cartridge systems were previously extremely limited. The new Blueline system changes all this – it opens up a host of totally new possibilities, allowing for the rapid, safe and clean processing of sensitive 2-K materials with the help of cartridge systems.

JEC in Paris

The JEC trade fair is the world’s largest composites exhibition, making it the ideal platform for Sulzer Mixpac to introduce its Blueline system and showcase its entire range of dispensers and cartridge-based application systems.

Blueline – key facts

  • For highly viscous materials that are difficult to apply
  • For high dispensing rates (threefold increase in dispensing quantity)
  • For materials sensitive to pressure and shearing
  • Compatible with commonly used MIXPAC dispensers

Sulzer Mixpac at JEC World 2017

Paris Nord Villepinte Exhibition Centre, hall 6, stand A62

Link to Press Kit

Contact:

Sulzer
Gerald Fleisch
Head of Marketing Sulzer Mixpac, Sulzer Mixpac Ltd
Tel: +41 (0)81 772 2164
gerald.fleisch@sulzer.com

Link:

ClickThru

Social Media:

https://www.facebook.com/SulzerMixpacUKLtd

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical Group Enters the Thai Market through Partnership with BLEZ14.11.2025 13:47:00 CET | Press release

-- Advancing Its Overseas Growth Strategy to Expand Japanese-Quality Aesthetic Medicine Across Asia Following Singapore -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. The partnership is a key component of SBC’s broader Asia strategy and represents a significant step toward full-scale entry into the rapidly growing Thai aesthetic medicine market. Under the agreement, SBC will provide comprehensive management support to a new clinic focused primarily on dermatological treatments such as pigmentation and spot removal, which BLEZ is preparing to open in

SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results14.11.2025 13:00:00 CET | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 million , representing an 353% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.12 for the three months ended September 30, 2025, compared to $0.03 in the same period of 2024. EBITDA1, which

Ant Group Chairman Eric Jing Outlines Strategy for Inclusive AI, Collaboration on Tokenised Settlement14.11.2025 11:15:00 CET | Press release

AI-as-a-Service applications will make AI virtual CFO and COO for SMEsPublic-private collaboration in regulatory sandboxes help to provide clarity and certainty when it comes to new technology like tokenisation and AI Eric Jing, Chairman of Ant Group, said the company's focus is on putting new payment and operation tools powered by AI and tokenisation technology in the hands of SMEs, to fully embrace the next wave of global productivity revolution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114239737/en/ Ant Group Chairman Eric Jing (second from right) shares insights during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on November 14, 2025. “We are passionate about using frontier technology to support SMEs and the use of AI will really uplift inclusion,” Jing said during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on Novem

Allianz Achieves Record Results and Expects a Full-Year Operating Profit of at Least 17 Billion Euros14.11.2025 07:16:00 CET | Press release

3Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113803211/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Double-digit growth in operating profit and shareholders’ core net incomeTotal business volume rises 5.21 percent with contributions from all segments Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income advances by 12.7 percent and reaches 2.9 billion euros 9M 2025 Continued strong and diversified growth across our businessesand record operating profitTotal business volume rises 8.5 1 percent and reaches 141.2 billion euros with contributions from all segments Operating profit increases 10.4 percent to 13.1 billion euros, our highest nine-month operating profit ever, reaching 82 percent of our full-year outlook midpoint Shareholders’ core net income advances 10.5 percent to 8.4 billion euros. Ad

Galderma Completes Successful Placement of CHF 175 Million Bond14.11.2025 07:00:00 CET | Press release

NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%. Net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing. The new bond will be listed on the SIX Swiss Exchange, with the settlement date expected on December 10, 2025. BNP Paribas and UBS jointly led the transaction. Galderma is rated BBB (stable outlook) by Fitch. The same rating is also expected to be assigned to the new bond. The successful issuance is leverage-ne

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye